Fundz

Amarna Therapeutics Announces Appointment of Dr Henk Streefkerk as New CEO

PRIVATEJun 07, 2023

Position

Chief Executive Officer

Company

Amarna Therapeutics

Henk Streefkerk
henk.streefkerk@amarnatherapeutics.com
LeidenManufacturingBiotechnologyHealth CareScience And EngineeringBiopharma

Description

Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Hemophilia B, today announces the appointment of Dr Henk Streefkerk as the Company's new Chief Executive Officer and Medical Director. He succeeds Steen Klysner, who served as CEO for the past three years. Streefkerk already was Amarna's Medical Director since mid-2022.

Quick answer

Amarna Therapeutics Announces Appointment of Dr Henk Streefkerk as New CEO (June 7, 2023). Amarna Therapeutics is based in Leiden, South Holland, Netherlands.

Who is the new Chief Executive Officer at Amarna Therapeutics?
Amarna Therapeutics named Henk Streefkerk Chief Executive Officer, announced June 7, 2023.
What did Amarna Therapeutics announce on June 7, 2023?
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Hemophilia B, today announces the appointment of Dr Henk Streefkerk as the Company's new Chief Executive Officer and Medical Director. He succeeds Steen Klysner, who served as CEO for the past three years.
What does Amarna Therapeutics do?
Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of rare and prevalent diseases.
Where is Amarna Therapeutics based?
Amarna Therapeutics is based in Leiden, South Holland, Netherlands.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (June 29, 2023), Wheeler Bio (June 6, 2023), Piramal Critical Care (June 6, 2023) and Zephyr AI, Inc. (June 5, 2023) also announced leadership changes within 45 days of Amarna Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Amarna Therapeutics, and when

A new leader at Amarna Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Amarna Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amarna Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amarna Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amarna Therapeutics

Location

Leiden, South Holland, Netherlands

About

Amarna Therapeutics is a privately held, pre-clinical biotech company developing transformative, potentially curative gene therapies for a range of rare and prevalent diseases. The company is pioneering the development of gene therapies based on simian virus 40 (SV40), a macaque polyoma virus to which humans are immunologically naïve. Amarna has created a proprietary production cell line (SuperVero) that for the first time makes it possible to produce SV40-derived vectors suitable for therapeutic use. The company's fully integrated gene therapy platform combining SuperVero with its genetically engineered SVec viral vector is truly unique in its intrinsic capability to deliver transgenes without eliciting immune responses to the vector nor to the transgene product. Leveraging this 'natural' non-immunogenicity feature of its gene delivery system in humans, Amarna is developing a broad pipeline of safe effective and durable gene therapies focused on genetic disorders, autoimmune diseases and chronic inflammation. Founded in 2008, Amarna's head office is based in Leiden Bio Science Park, the Netherlands, with a research subsidiary located in Seville, Spain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amarna Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Henk
Likely contact at this company
••••••••@••••••••

See Henk's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Amarna Therapeutics's next move

Learn about Strategic plan

Amarna Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.